Sign in
Not yet recruitingNo phase

Ultrasound compared with angiography for leg artery blockages in chronic limb threatening ischemia

Checks how well ultrasound finds leg artery damage compared with angiography.

Key facts

Who runs it
Sohag University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Duplex Ultrasound Versus Conventional Angiography in Evaluating Lower Limb Threatening Ischemia
Status
Not yet recruiting
People taking part
50 people, planned
Started
2 Sept 2025
Planned end
2 Apr 2026
Type of study
Interventional
Treatments tested
  • conventional angiography
Record updated
8 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic threatening lower limb ischemia, meaning poor blood flow to the leg. It compares Duplex Ultrasound with angiography, an X-ray scan of the arteries.

Age
40 Years and older
Sex
All sexes
Disease stage
Chronic threatening lower limb ischemia, with pain at rest, a wound that does not heal, or gangrene.

Main reasons for not taking part

  • Unstable blood pressure or circulation, so the person is not fit for angiography
  • Artery disease not caused by hardening of the arteries, such as vasculitis or Buerger's disease
  • Known allergy to contrast dye, or kidney problems that rule out contrast angiography
  • A full Duplex Ultrasound exam is not possible, for example the ultrasound cannot see the arteries clearly
  • Not able to give informed consent

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • 1. Clinical diagnosis of chronic threatening lower limb ischemia (rest pain, non-healing ulcer, or gangrene)
  • Ability to provide informed consent

Who cannot take part

  • 1. Hemodynamically unstable patients not fit for angiography. 2. Patients with non-atherosclerotic arterial diseases (e.g., vasculitis, Buerger's disease); Known contrast allergy or renal insufficiency precluding contrast angiography; Inadequate acoustic window or inability to undergo complete DUS examination

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the accuracy of Duplex Ultrasound (DUS) in assessing infra inguinal arterial lesions in patients with chronic threatening limb ischemia compared with digital subtraction angiography (DSA) as the reference standard. By comparing sensitivity, specificity, and predictive values across arterial segments, the study seeks to determine the clinical utility of DUS as a non-invasive alternative for pre-intervention vascular mapping in chronic limb-threatening ischemia.

The group in the trial

  • patients with chronic threatening limb ischemiaTreatment being tested

    Duplex Ultrasound (DUS) assessment of infra inguinal arterial lesions in patients with chronic threatening limb ischemia and then compared with digital subtraction angiography (DSA) as the reference standard.

    Treatment: conventional angiography

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Diagnostic Value of Duplex Ultrasound in Evaluating Infra Inguinal Arteries in Patients With Chronic Limb Threatening Ischemia : A Comparative Study With Angiography
Plain-language title
Ultrasound compared with angiography for leg artery blockages in chronic limb threatening ischemiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
8 August 2025